Amifostine trihydrate
≥97%
- Product Code: 103397
CAS:
112901-68-5
| Molecular Weight: | 268.27 g./mol | Molecular Formula: | C₅H₁₅N₂O₃PS₃H₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00453866 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Amifostine trihydrate is primarily used as a cytoprotective agent in cancer therapy. It helps protect healthy tissues from the damaging effects of radiation therapy and certain chemotherapy drugs, particularly cisplatin. By selectively shielding normal cells, it reduces side effects such as kidney toxicity, hearing loss, and damage to the bone marrow. It is commonly administered intravenously before chemotherapy or radiation sessions. Additionally, it has been explored in the prevention of dry mouth (xerostomia) in patients undergoing radiotherapy for head and neck cancers. Its ability to selectively protect healthy cells while allowing cancer cells to remain vulnerable makes it a valuable adjunct in oncology treatments.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Powder |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $12.00 |
+
-
|
| 0.010 | 10-20 days | $20.70 |
+
-
|
| 0.050 | 10-20 days | $51.61 |
+
-
|
| 0.250 | 10-20 days | $141.61 |
+
-
|
| 1.000 | 10-20 days | $282.63 |
+
-
|
Amifostine trihydrate
Amifostine trihydrate is primarily used as a cytoprotective agent in cancer therapy. It helps protect healthy tissues from the damaging effects of radiation therapy and certain chemotherapy drugs, particularly cisplatin. By selectively shielding normal cells, it reduces side effects such as kidney toxicity, hearing loss, and damage to the bone marrow. It is commonly administered intravenously before chemotherapy or radiation sessions. Additionally, it has been explored in the prevention of dry mouth (xerostomia) in patients undergoing radiotherapy for head and neck cancers. Its ability to selectively protect healthy cells while allowing cancer cells to remain vulnerable makes it a valuable adjunct in oncology treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :